NCT05766384 Hyperpolarized 129Xe MRI Lung Health Cohort
| NCT ID | NCT05766384 |
| Status | Recruiting |
| Phase | — |
| Sponsor | University of Kansas Medical Center |
| Condition | Healthy |
| Study Type | OBSERVATIONAL |
| Enrollment | 260 participants |
| Start Date | 2023-11-30 |
| Primary Completion | 2027-03-31 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
This is an observational study. You will not receive an experimental treatment; researchers will collect data based on your existing condition or standard treatment.
This trial targets 260 participants in total. It began in 2023-11-30 with a primary completion date of 2027-03-31.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
A subset of young adults participating in the American Lung Association (ALA) Lung Health Cohort (LHC) will be imaged using Hyperpolarized 129Xe MRI to assess lung structure and function. Images will be used to improve the understanding of lung health and early lung abnormalities that may lead to chronic lung disease.
Eligibility Criteria
Inclusion Criteria: * Is enrolled in the American Lung Association Lung Health Cohort Study. * Has completed CT imaging for the LHC study within 2 years of the scheduled Xe-MRI date. Exclusion Criteria: * Pacemaker, internal defibrillator or other implanted electronic devices or any standard MRI contraindications (e.g., claustrophobia, \> 140 cm shoulder circumference, dependent on weight distribution). * Is pregnant or breastfeeding * Oxygen saturation (SpO2) \<88% on room air or with supplemental oxygen.
Contact & Investigator
Frequently Asked Questions
Who can join the NCT05766384 clinical trial?
This trial is open to participants of all sexes, aged 25 Years or older, up to 35 Years, studying Healthy. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT05766384 currently recruiting?
Yes, NCT05766384 is actively recruiting participants. Contact the research team at chernandez@kumc.edu for enrollment information.
Where is the NCT05766384 trial being conducted?
This trial is being conducted at Chicago, United States, Iowa City, United States, Kansas City, United States, Durham, United States and 2 additional locations.
Who is sponsoring the NCT05766384 clinical trial?
NCT05766384 is sponsored by University of Kansas Medical Center. The trial plans to enroll 260 participants.